Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document

• Published in: Allergy (Copenhagen) Vol. 74; no. 3; pp. 449 - 463
• Main Authors: Agache, Ioana, Miller, Rachel, Gern, James E., Hellings, Peter W., Jutel, Marek, Muraro, Antonella, Phipatanakul, Wanda, Quirce, Santiago, Peden, David
• Format: Journal Article
• Language: English
• Published: Denmark Blackwell Publishing Ltd 01-03-2019
• Subjects: Allergic diseases; Allergies; Asthma; Asthma - diagnosis; Asthma - epidemiology; Asthma - etiology; Asthma - metabolism; Big Data; Biomarkers; Disease Susceptibility; environment; Europe; Exposome; Exposure; Genetic Predisposition to Disease; Genomics - methods; Humans; Hypersensitivity; Hypersensitivity - diagnosis; Hypersensitivity - epidemiology; Hypersensitivity - etiology; Hypersensitivity - metabolism; Immunology; Life span; PRACTALL; Precision Medicine; Proteomics - methods; Risk Assessment; Risk Factors; United States; United States; Europe; environment; asthma; exposome; biomarkers; PRACTALL; allergic diseases
• ISSN: 0105-4538; 1398-9995
• DOI: 10.1111/all.13690

Exposome research can improve the understanding of the mechanistic connections between exposures and health to help mitigate adverse health outcomes across the life span. The exposomic approach provides a risk profile instead of single predictors and thus is particularly applicable to allergic diseases and asthma. Under the PRACTALL collaboration between the European Academy of Allergy and Clinical Immunology (EAACI) and the American Academy of Allergy, Asthma, and Immunology (AAAAI), we evaluated the current concepts and the unmet needs on the role of the exposome in allergic diseases and asthma.